Kardium Inc. Raises $104M to Develop Atrial Fibrillation Treatment

Kardium Inc. raises $104M for Atrial Fibrillation Treatment

Kardium Inc. (Linkedin), a Canadian medical equipment manufacturing company, recently secured $104M in funding to advance their Globe Mapping and Ablation System for the treatment of atrial fibrillation. With the support of leading investors, Kardium aims to revolutionize cardiac care and improve outcomes for patients worldwide.

Funding Amount: $104 million

Industry: Medical Equipment Manufacturing

Employee Count: 51-200

CEO: Kevin Chaplin (CEO Linkedin)

What Kardium Inc. needs to buy: Kardium Inc. is seeking partnerships with research organizations, regulatory consultants, and suppliers of manufacturing equipment and supplies. Additionally, they are looking to build a clinical support and commercial team to prepare for the launch of their Globe System. Companies specializing in clinical research, regulatory support, and medical equipment manufacturing are ideal partners for Kardium Inc.'s expansion and commercialization efforts.